Phibro Animal Health Corporation Class A Common Stock represents ownership in Phibro Animal Health Corporation, a global animal health and mineral nutrition company. Phibro develops, manufactures, and markets products for food-producing and companion animals, supporting sectors such as poultry, swine, beef and dairy cattle, aquaculture, and pets. Its portfolio spans animal health solutions, mineral nutrition products, and performance products used in livestock production and animal care. The company serves customers across the agricultural and veterinary supply chains, where its offerings help address nutrition, health, and productivity needs in animal operations. Phibro Animal Health Corporation is headquartered in Teaneck, New Jersey, and its Class A common stock is one of the company’s primary publicly traded equity classes.
WebsiteGlenpointe Centre East
Teaneck, NJ, 07666-6712
United States
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Shareholders of Phibro Animal Health would probably like to forget the past six months even happened. The stock dropped 38.5% and now trades at $34.11. This may have investors wondering how to approach the situation.
TEANECK, N.J., September 09, 2026--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference.
Phibro Animal Health earnings and guidance set the tone Phibro Animal Health (PAHC) drew investor attention after issuing earnings guidance for the fiscal year ending June 30, 2027, alongside reporting fourth quarter and full year 2026 results. The company now projects 2027 net sales of US$1.55b to US$1.60b and net income of US$122 million to US$132 million. Expected diluted EPS is US$2.98 to US$3.22. These figures follow 2026 sales of US$1,518.09 million and net income of US$99.72...
Investors talking about PAHC also mention
What share of all stock conversation is about PAHC?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% new | 0% 0 | 0% +0 |
Of the messages about PAHC that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | 100% 0 | 98.26% +1.67 | ||
| Bearish | — | — | 0% 0 | 1.74% -1.67 |
Of the messages about PAHC that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Earnings | — | — | 57.14% | 2.74% | ||
| Announcements | — | — | 42.86% | 43.14% | ||
| Analysts | — | — | 0% | 6.48% | ||
| Controversies | — | — | 0% | 0% | ||
| Macro | — | — | 0% | 8.98% | ||
| Technical Analysis | — | — | 0% | 38.65% |
Of the messages about PAHC, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 100% | 75.86% | 52.84% | ||
| Newcomers | — | 0% | 24.14% | 47.16% |